Trogenix
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $110M
Investors
- 10
About Trogenix
Founded in 2023 and based in the UK, Trogenix Ltd. is engaged in delivering therapies for glioblastoma. Trogenix engaged in developing therapies targeting glioblastoma through its Odysseus Platform, which is designed to deliver Precision Therapies including Synthetic Super-Enhancers (SSEs). The company’s lead program focuses on treatments that have demonstrated curative potential in preclinical studies. Trogenix's core offerings are tailored for oncologists and healthcare institutions that seek solutions for glioblastoma management. Trogenix engages in a structured revenue model predominantly through partnerships with healthcare providers and research institutions, facilitating B2B transactions focused on the advanced treatment of glioblastoma. The company’s revenue generation is anchored in collaborative agreements that may involve milestone payments tied to specific clinical development phases, as well as royalties on future sales of therapies derived from its technology platform.
Who invested in Trogenix
10 investors across 2 rounds
See all investors in Trogenix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Trogenix
Who invested in Trogenix?
Trogenix has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trogenix raised?
Trogenix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Trogenix last raise money?
Trogenix's most recent round on record is a Series A, in Oct 2025.
What does Trogenix do?
Founded in 2023 and based in the UK, Trogenix Ltd.
Where is Trogenix headquartered?
Trogenix is headquartered in Edinburgh, UK.
Which VCs invest in companies like Trogenix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Trogenix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Trogenix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.